Alexion Latest BioScience Headliner in CT; Industry Depth Grows
/The impending arrival of Jackson Labs in Farmington, the year’s blockbuster deal in Connecticut’s efforts to build its economic base in the biotech industry into national leadership, is far from the only game in town. Connecticut is already home to 800 biomedical companies, according to data from D&B Sale & Marketing Solutions (2011) as reported in the Connecticut Economic Review, produced by Northeast Utilities. Connecticut’s 10 largest biomedical companies (alphabetically):
- Alexion Pharmaceuticals
- Boehringer Ingelheim
- Bristol-Meyers Squibb
- Clinical Laboratory Partners
- Dianon Systems
- Hamilton Sunstrand
- Pfizer
- Pharmaceutical Research Associates
- United States Surgical
- Zygo
Alexion Pharmaceuticals Inc. announced this week that it will open a new headquarters in New Haven, adding hundreds of jobs to the region with the help of state financial backing.
Under the deal, Alexion will move and consolidate more than 350 workers that are currently spread over several buildings in Cheshire, to a new 400,000-square-foot facility with office, laboratory and research and development space. Alexion will be the anchor tenant in a $100 million facility that will be a centerpiece of New Haven's downtown redevelopment efforts known as Downtown Crossing. The company returns to New Haven, where it began in a small office in the city's Science Park.
